Edition:
United States

Harvard Bioscience Inc (HBIO.OQ)

HBIO.OQ on NASDAQ Stock Exchange Global Market

5.75USD
20 Apr 2018
Change (% chg)

$0.05 (+0.88%)
Prev Close
$5.70
Open
$5.70
Day's High
$5.75
Day's Low
$5.70
Volume
21,153
Avg. Vol
23,419
52-wk High
$6.05
52-wk Low
$2.30

Chart for

About

Harvard Bioscience, Inc. is a developer, manufacturer and marketer of a range of scientific instruments, systems and lab consumables used for basic research, drug discovery, clinical and environmental testing. The Company's products are sold to thousands of researchers in over 100 countries through its global sales organization,... (more)

Overall

Beta: 1.33
Market Cap(Mil.): $204.72
Shares Outstanding(Mil.): 35.60
Dividend: --
Yield (%): --

Financials

  HBIO.OQ Industry Sector
P/E (TTM): 122.11 33.33 33.60
EPS (TTM): 0.05 -- --
ROI: 1.76 9.89 13.19
ROE: 2.16 14.70 15.00

BRIEF-Harvard Bioscience Reports Q4 GAAP Earnings Per Share $0.03

* HARVARD BIOSCIENCE REPORTS FOURTH QUARTER AND YEAR-END 2017 RESULTS

Mar 01 2018

BRIEF-Harvard Bioscience Says Co Entered Into A Financing Agreement

* HARVARD BIOSCIENCE INC - ON JAN 31, 2018, CO ENTERED INTO A FINANCING AGREEMENT - SEC FILING

Feb 02 2018

BRIEF-Harvard Bioscience To Acquire Data Sciences International

* HARVARD BIOSCIENCE TO ACQUIRE DATA SCIENCES INTERNATIONAL AND SELLS DENVILLE SCIENTIFIC

Jan 22 2018

BRIEF-Harvard Bioscience reports Q3 loss $0.01/shr

* Harvard Bioscience reports third quarter 2017 financial results

Oct 26 2017

BRIEF-Harvard Bioscience appoints Katherine Eade, Thomas Loewald to board

* Harvard Bioscience appoints Katherine Eade and Thomas Loewald to the board of directors Source text for Eikon: Further company coverage:

Oct 25 2017

Earnings vs. Estimates